Long-term effects of empagliflozin in patients with chronic kidney disease

Two years of empagliflozin slowed kidney disease progression and reduced cardiovascular risk. In this post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation.

Saved in:
Bibliographic Details
Main Authors: Herrington, William G. (Author) , Hauske, Sibylle J. (Author) , Brückmann, Martina (Author)
Format: Article (Journal)
Language:English
Published: February 20, 2025
In: The New England journal of medicine
Year: 2025, Volume: 392, Issue: 8, Pages: 777-787
ISSN:1533-4406
DOI:10.1056/NEJMoa2409183
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa2409183
Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/full/10.1056/NEJMoa2409183
Get full text
Author Notes:the EMPA‑KIDNEY Collaborative Group
Description
Summary:Two years of empagliflozin slowed kidney disease progression and reduced cardiovascular risk. In this post-trial study, empagliflozin had additional cardiorenal benefits after discontinuation.
Item Description:Online veröffentlicht: 25. Oktober 2024
Mitglieder des "writing committee": William G. Herrington, F.R.C.P., Natalie Staplin, Ph.D., Nikita Agrawal, M.B., B.Chir., Christoph Wanner, M.D., Jennifer B. Green, M.D., Sibylle J. Hauske, Ph.D., Jonathan R. Emberson, Ph.D., David Preiss, Ph.D., Parminder Judge, Ph.D., Doreen Zhu, M.D., Rejive Dayanandan, M.Sc., Ryoki Arimoto, M.B., B.S., Kaitlin J. Mayne, M.B., Ch.B., Sarah Y.A. Ng, Ph.D., Emily Sammons, M.B., Ch.B., Michael Hill, D.Phil., Will Stevens, Ph.D., Karl Wallendszus, M.Sc., Susanne Brenner, M.D., Alfred K. Cheung, M.D., Zhi‑Hong Liu, M.D., Ph.D., Jing Li, Ph.D., Lai Seong Hooi, F.R.C.P., Wen Liu, F.R.C.P., Takashi Kadowaki, M.D., Ph.D., Masaomi Nangaku, M.D., Ph.D., Adeer Levin, M.D., David Z.I Cherney, M.D., Ph.D., Aldo P. Maggioni, M.D., Roberto Pontremoli, M.D., Rajat Deo, M.D., Shinya Goto, M.D., Ph.D., Xavier Rossello, Ph.D., Katherine R. Tuttle, M.D., Dominik Steubl, M.D., Dan Massey, M.Sc., Martina Brueckmann, M.D., Martin J. Landray, F.Med.Sci., Colin Baigent, F.Med.Sci., and Richard Haynes, D.M
Gesehen am 23.02.2026
Physical Description:Online Resource
ISSN:1533-4406
DOI:10.1056/NEJMoa2409183